Owlet, Inc. has 6 Schedule 13D or 13G filings on record since 2025-07-10. 4 holders' latest filing reports 5% or more of class a common stock, $0.0001 par value. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Eclipse Continuity GP I, LLC | 40.5% | 1,066,472 | SCHEDULE 13D/A, 2025-10-15 | 2025-10-10 |
| Trilogy Equity Partners, LLC | 8.7% | 2,022,178 | SCHEDULE 13D/A, 2025-10-15 | 2025-10-10 |
| Kinderhook 2 GP LLC | 6.89% | 1,138,278 | SCHEDULE 13G/A, 2025-07-10 | 2025-06-30 |
| Granahan Investment Management LLC | 5.5% | 1,595,419 | SCHEDULE 13G, 2026-08-11 | 2026-06-30 |
| AWM Investment Company, Inc. | 4.2% | 1,225,353 | SCHEDULE 13G/A, 2026-08-14 | 2026-06-30 |
Purpose of Transaction (Item 4)
Eclipse Continuity GP I, LLC
Item 4 of the Original Schedule 13D is hereby amended and supplement by adding the following to the end of Item 4: On August 7, 2025, the Issuer entered into an Exchange Agreement with certain investors, including Eclipse EGF I (the "Warrant Exchange Agreement"), pursuant to which Eclipse EGF I exchanged 5,300,921 Series A Warrants and 1,166,935 Series B Warrants for an aggregate of 3,898,906 shares of the Issuer's Class A Common Stock for no additional consideration (the "Warrant Exchange"). The Warrant Exchange closed on October 10, 2025. The above summary of the Warrant Exchange Agreement is qualified by reference to such description and the full text of the Form of Warrant Exchange Agreement, a form of which is filed as Exhibit 1 to this Statement and is incorporated by reference herein. Except as set forth above, the Reporting Persons have no present plans or intentions which would result in or relate to any of the transactions described in subparagraphs (a) through (j) of Item 4 of the Original Schedule 13D.Item 4 of the SCHEDULE 13D/A filed 2025-10-15
Trilogy Equity Partners, LLC
Item 4(a) is amended and supplemented to add the following: The information in Item 5(c) of this Amendment No. 4 is incorporated by reference herein.Item 4 of the SCHEDULE 13D/A filed 2025-10-15
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-07-10 | Kinderhook 2 GP LLC | 6.89% | SCHEDULE 13G/A |
| 2025-10-15 | Eclipse Continuity GP I, LLC | 40.5% | SCHEDULE 13D/A |
| 2025-10-15 | Trilogy Equity Partners, LLC | 8.7% | SCHEDULE 13D/A |
| 2026-02-13 | AWM Investment Company, Inc. | 6.3% | SCHEDULE 13G |
| 2026-08-11 | Granahan Investment Management LLC | 5.5% | SCHEDULE 13G |
| 2026-08-14 | AWM Investment Company, Inc. | 4.2% | SCHEDULE 13G/A |
Tools for this story
Each opens in a new tab, filled in for Owlet, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.